Modulation of HER3 is a marker of dynamic cell signaling in ovarian cancer Implications for Pertuzumab Sensitivity: implications for Pertuzumab sensitivity

Yoko Nagumo, Dana Faratian, Peter Mullen, David J. Harrison, Max Hasmann, Simon P. Langdon

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Modulation of HER3 is a marker of dynamic cell signaling in ovarian cancer Implications for Pertuzumab Sensitivity: implications for Pertuzumab sensitivity'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology